GENE ONLINE|News &
Opinion
Blog

2024-03-06|

Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference

by GeneOnline
Share To

DUBLIN, March 6, 2024 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 26th annual Barclays global healthcare conference on Tuesday, March 12, 2024.

Karen Parkhill, Medtronic executive vice president and chief financial officer, will answer questions on the company beginning at 8:00 a.m. EDT (7:00 a.m. CDT).

A live webcast of the Q&A session will be available on March 12, 2024, by clicking on the Events link at http://investorrelations.medtronic.com. An archive of the Q&A session will be available on the same webpage later in the day.

 
©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Medtronic Bags FDA Authorization for Pioneering Medical Device to Combat Pediatric Diabetes
2020-09-02
Med X Tech Summit Asia (MEDTEX) 2018 – Overview of Day 2 Program
2018-11-23
LATEST
First Person to Receive Transplanted Pig Kidney has Died
2024-05-13
Kexing Biopharm Facility Passes EU GMP Certification for Paclitaxel for Injection (Albumin Bound)
2024-05-10
Biotech in Beauty: Engineered Skin Bacteria Designed To Treat Acne
2024-05-10
Revolutionizing Treatment: ASGCT’s Clinical Trials Spotlight on Immunotherapy, Cancer Vaccines, and Auditory Diseases
2024-05-09
Advancing Health: ASGCT’s Clinical Trials Spotlight on Cell Therapy and Cell-Based Gene Therapy
2024-05-09
Infinitopes’ Article in Peer-Reviewed Journal Seeks to Unlock the Potential of Cancer Vaccines
2024-05-09
Profluent Achieves Human Genome Editing Milestone Using OpenCRISPR-1: The First AI-Generated, Open-Source Gene Editor
2024-05-08
EVENT
Scroll to Top